How Cathie Wood's Fund Gave Us A Back Door To Moderna's Breakthrough The recent surge in Moderna's stock has left many investors scrambling to join the party, but a closer examination reveals a more complex web of connections.
Cathie Wood's fund, ARK Invest, has been making waves with its unconventional investment strategies, which have contributed significantly to the stock's rise.
Moderna's COVID 19 vaccine has been a game changer in the fight against the pandemic, and its success is often attributed to the company's innovative approach.